FDA Proposes Regulatory Framework for AI- and Machine Learning-Driven SaMD
The US Food and Drug Administration (FDA) requests feedback on a new discussion paper that proposes applying a “focused review” approach to premarket assessments of software as a medical device (SaMD) technologies that are powered by artificial intelligence (AI) and machine learning (ML).
In silico models for drug development: tackling the validation challenge
A two-days workshop was organised in Leuven on 25-26 April 2019 to discuss how to tackle the validation challenge of in silico models for drug development.
Vacancy for a Principal Scientist on Multiphysics at Philips - Eindhoven
A vacancy of interest for the VPH community is now available at the Philips Multi-physics & Optics department.